Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-004400·TUDOR INVESTMENT CORP ET AL
Schedule 13G ownership disclosure
SCPHARMACEUTICALS INC
Common Stock, par value $0.0001 per share · CUSIP: 810648105
Event date: 2025-10-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Tudor Investment Corporation
Shares: 0.00 · Class: 0%
- Paul T. Jones II
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004400
- Form type
- SCHEDULE 13G
- Filer
- TUDOR INVESTMENT CORP ET AL
- CIK
- CIK 923093
- Filed
- Oct 14, 2025
- Reporting period
- Oct 06, 2025
- Description
- Schedule 13G beneficial ownership